DNA Vaccination
DNA Vaccination market is segmented by region (country), players, by Type and by Application. Pla ... Read More
Global and United States Adult and Pediatric Vaccines Market Report & Forecast 2023-2028
1 Study Coverage
1.1 Adult and Pediatric Vaccines Revenue in Adult and Pediatric Vaccines Business (2017-2022) & (US$ Million) Introduction
1.2 Global Adult and Pediatric Vaccines Outlook 2017 VS 2022 VS 2028
1.2.1 Global Adult and Pediatric Vaccines Market Size for the Year 2017-2028
1.2.2 Global Adult and Pediatric Vaccines Market Size for the Year 2017-2028
1.3 Adult and Pediatric Vaccines Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.3.1 The Market Share of United States Adult and Pediatric Vaccines in Global, 2017 VS 2022 VS 2028
1.3.2 The Growth Rate of Adult and Pediatric Vaccines Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4 Adult and Pediatric Vaccines Market Dynamics
1.4.1 Adult and Pediatric Vaccines Industry Trends
1.4.2 Adult and Pediatric Vaccines Market Drivers
1.4.3 Adult and Pediatric Vaccines Market Challenges
1.4.4 Adult and Pediatric Vaccines Market Restraints
1.5 Study Objectives
1.6 Years Considered
2 Adult and Pediatric Vaccines by Type
2.1 Adult and Pediatric Vaccines Market Segment by Type
2.1.1 Adult Vaccines
2.1.2 Pediatric Vaccines
2.2 Global Adult and Pediatric Vaccines Market Size by Type (2017, 2022 & 2028)
2.3 Global Adult and Pediatric Vaccines Market Size by Type (2017-2028)
2.4 United States Adult and Pediatric Vaccines Market Size by Type (2017, 2022 & 2028)
2.5 United States Adult and Pediatric Vaccines Market Size by Type (2017-2028)
3 Adult and Pediatric Vaccines by Application
3.1 Adult and Pediatric Vaccines Market Segment by Application
3.1.1 Hospitals
3.1.2 Medical Care Centers
3.1.3 Others
3.2 Global Adult and Pediatric Vaccines Market Size by Application (2017, 2022 & 2028)
3.3 Global Adult and Pediatric Vaccines Market Size by Application (2017-2028)
3.4 United States Adult and Pediatric Vaccines Market Size by Application (2017, 2022 & 2028)
3.5 United States Adult and Pediatric Vaccines Market Size by Application (2017-2028)
4 Global Adult and Pediatric Vaccines Competitor Landscape by Company
4.1 Global Adult and Pediatric Vaccines Market Size by Company
4.1.1 Top Global Adult and Pediatric Vaccines Companies Ranked by Revenue (2021)
4.1.2 Global Adult and Pediatric Vaccines Revenue by Player (2017-2022)
4.2 Global Adult and Pediatric Vaccines Concentration Ratio (CR)
4.2.1 Adult and Pediatric Vaccines Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Companies of Adult and Pediatric Vaccines in 2021
4.2.3 Global Adult and Pediatric Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Adult and Pediatric Vaccines Headquarters, Revenue in Adult and Pediatric Vaccines Business (2017-2022) & (US$ Million) Type
4.3.1 Global Adult and Pediatric Vaccines Headquarters and Area Served
4.3.2 Global Adult and Pediatric Vaccines Companies Revenue in Adult and Pediatric Vaccines Business (2017-2022) & (US$ Million) Type
4.3.3 Date of International Companies Enter into Adult and Pediatric Vaccines Market
4.4 Companies Mergers & Acquisitions, Expansion Plans
4.5 United States Adult and Pediatric Vaccines Market Size by Company
4.5.1 Top Adult and Pediatric Vaccines Players in United States, Ranked by Revenue (2021)
4.5.2 United States Adult and Pediatric Vaccines Revenue by Players (2020, 2021 & 2022)
5 Global Adult and Pediatric Vaccines Market Size by Region
5.1 Global Adult and Pediatric Vaccines Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Adult and Pediatric Vaccines Market Size by Region (2017-2028)
5.2.1 Global Adult and Pediatric Vaccines Market Size by Region: 2017-2022
5.2.2 Global Adult and Pediatric Vaccines Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Adult and Pediatric Vaccines Market Size YoY Growth 2017-2028
6.1.2 North America Adult and Pediatric Vaccines Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Adult and Pediatric Vaccines Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Adult and Pediatric Vaccines Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Adult and Pediatric Vaccines Market Size YoY Growth 2017-2028
6.3.2 Europe Adult and Pediatric Vaccines Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Adult and Pediatric Vaccines Market Size YoY Growth 2017-2028
6.4.2 Latin America Adult and Pediatric Vaccines Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Adult and Pediatric Vaccines Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Adult and Pediatric Vaccines Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 GlaxoSmithKline
7.1.1 GlaxoSmithKline Company Details
7.1.2 GlaxoSmithKline Business Overview
7.1.3 GlaxoSmithKline Adult and Pediatric Vaccines Introduction
7.1.4 GlaxoSmithKline Revenue in Adult and Pediatric Vaccines Business (2017-2022)
7.1.5 GlaxoSmithKline Recent Development
7.2 Sanofi
7.2.1 Sanofi Company Details
7.2.2 Sanofi Business Overview
7.2.3 Sanofi Adult and Pediatric Vaccines Introduction
7.2.4 Sanofi Revenue in Adult and Pediatric Vaccines Business (2017-2022)
7.2.5 Sanofi Recent Development
7.3 Merck
7.3.1 Merck Company Details
7.3.2 Merck Business Overview
7.3.3 Merck Adult and Pediatric Vaccines Introduction
7.3.4 Merck Revenue in Adult and Pediatric Vaccines Business (2017-2022)
7.3.5 Merck Recent Development
7.4 Novartis
7.4.1 Novartis Company Details
7.4.2 Novartis Business Overview
7.4.3 Novartis Adult and Pediatric Vaccines Introduction
7.4.4 Novartis Revenue in Adult and Pediatric Vaccines Business (2017-2022)
7.4.5 Novartis Recent Development
7.5 Pfizer
7.5.1 Pfizer Company Details
7.5.2 Pfizer Business Overview
7.5.3 Pfizer Adult and Pediatric Vaccines Introduction
7.5.4 Pfizer Revenue in Adult and Pediatric Vaccines Business (2017-2022)
7.5.5 Pfizer Recent Development
7.6 AstraZeneca
7.6.1 AstraZeneca Company Details
7.6.2 AstraZeneca Business Overview
7.6.3 AstraZeneca Adult and Pediatric Vaccines Introduction
7.6.4 AstraZeneca Revenue in Adult and Pediatric Vaccines Business (2017-2022)
7.6.5 AstraZeneca Recent Development
7.7 Johnson and Johnson
7.7.1 Johnson and Johnson Company Details
7.7.2 Johnson and Johnson Business Overview
7.7.3 Johnson and Johnson Adult and Pediatric Vaccines Introduction
7.7.4 Johnson and Johnson Revenue in Adult and Pediatric Vaccines Business (2017-2022)
7.7.5 Johnson and Johnson Recent Development
7.8 Takeda Pharmaceutical
7.8.1 Takeda Pharmaceutical Company Details
7.8.2 Takeda Pharmaceutical Business Overview
7.8.3 Takeda Pharmaceutical Adult and Pediatric Vaccines Introduction
7.8.4 Takeda Pharmaceutical Revenue in Adult and Pediatric Vaccines Business (2017-2022)
7.8.5 Takeda Pharmaceutical Recent Development
7.9 Bavarian Nordic
7.9.1 Bavarian Nordic Company Details
7.9.2 Bavarian Nordic Business Overview
7.9.3 Bavarian Nordic Adult and Pediatric Vaccines Introduction
7.9.4 Bavarian Nordic Revenue in Adult and Pediatric Vaccines Business (2017-2022)
7.9.5 Bavarian Nordic Recent Development
7.10 LG Life Sciences
7.10.1 LG Life Sciences Company Details
7.10.2 LG Life Sciences Business Overview
7.10.3 LG Life Sciences Adult and Pediatric Vaccines Introduction
7.10.4 LG Life Sciences Revenue in Adult and Pediatric Vaccines Business (2017-2022)
7.10.5 LG Life Sciences Recent Development
7.11 Sinovac Biotech
7.11.1 Sinovac Biotech Company Details
7.11.2 Sinovac Biotech Business Overview
7.11.3 Sinovac Biotech Adult and Pediatric Vaccines Introduction
7.11.4 Sinovac Biotech Revenue in Adult and Pediatric Vaccines Business (2017-2022)
7.11.5 Sinovac Biotech Recent Development
8 Research Findings and Conclusion
9 Appendix
9.1 Research Methodology
9.1.1 Methodology/Research Approach
9.1.2 Data Source
9.2 Author Details
9.3 Disclaimer
List of Tables
Table 1. Adult and Pediatric Vaccines Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
Table 2. Adult and Pediatric Vaccines Market Trends
Table 3. Adult and Pediatric Vaccines Market Drivers
Table 4. Adult and Pediatric Vaccines Market Challenges
Table 5. Adult and Pediatric Vaccines Market Restraints
Table 6. Global Adult and Pediatric Vaccines Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Adult and Pediatric Vaccines Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Adult and Pediatric Vaccines Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Adult and Pediatric Vaccines Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Adult and Pediatric Vaccines Companies in Global Market, Ranking by Revenue (2021)
Table 11. Global Adult and Pediatric Vaccines Revenue by Player, (US$ Million), 2017-2022
Table 12. Global Adult and Pediatric Vaccines Revenue Share by Player, 2017-2022
Table 13. Global Adult and Pediatric Vaccines Companies Market Concentration Ratio (CR5 and HHI)
Table 14. Global Adult and Pediatric Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Adult and Pediatric Vaccines as of 2021)
Table 15. Top Players of Adult and Pediatric Vaccines in Global Market, Headquarters and Area Served
Table 16. Companies Revenue in Adult and Pediatric Vaccines Business (2017-2022) & (US$ Million) Type
Table 17. Date of International Companies Enter into Adult and Pediatric Vaccines Market
Table 18. Companies Mergers & Acquisitions, Expansion Plans
Table 19. Top Adult and Pediatric Vaccines Players in United States Market, Ranking by Revenue (2021)
Table 20. United States Adult and Pediatric Vaccines Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 21. United States Adult and Pediatric Vaccines Revenue Share by Players, 2020, 2021 & 2022
Table 22. Global Adult and Pediatric Vaccines Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 23. Global Adult and Pediatric Vaccines Market Size by Region (2017-2022) & (US$ Million)
Table 24. Global Adult and Pediatric Vaccines Market Size Forecast by Region (2023-2028) & (US$ Million)
Table 25. North America Adult and Pediatric Vaccines Sales in Value by Country (2017-2028) & (US$ Million)
Table 26. Asia Pacific Adult and Pediatric Vaccines Sales in Value by Region (2017-2028) & (US$ Million)
Table 27. Europe Adult and Pediatric Vaccines Sales in Value by Country (2017-2028) & (US$ Million)
Table 28. Latin Americaa Adult and Pediatric Vaccines Sales in Value by Country (2017-2028) & (US$ Million)
Table 29. Middle East and Africa Adult and Pediatric Vaccines Sales in Value by Country (2017-2028) & (US$ Million)
Table 30. GlaxoSmithKline Company Details
Table 31. GlaxoSmithKline Business Overview
Table 32. GlaxoSmithKline Adult and Pediatric Vaccines Product
Table 33. GlaxoSmithKline Revenue in Adult and Pediatric Vaccines Business (2017-2022) & (US$ Million)
Table 34. GlaxoSmithKline Recent Development
Table 35. Sanofi Company Details
Table 36. Sanofi Business Overview
Table 37. Sanofi Adult and Pediatric Vaccines Product
Table 38. Sanofi Revenue in Adult and Pediatric Vaccines Business (2017-2022) & (US$ Million)
Table 39. Sanofi Recent Development
Table 40. Merck Company Details
Table 41. Merck Business Overview
Table 42. Merck Adult and Pediatric Vaccines Product
Table 43. Merck Revenue in Adult and Pediatric Vaccines Business (2017-2022) & (US$ Million)
Table 44. Merck Recent Development
Table 45. Novartis Company Details
Table 46. Novartis Business Overview
Table 47. Novartis Adult and Pediatric Vaccines Product
Table 48. Novartis Revenue in Adult and Pediatric Vaccines Business (2017-2022) & (US$ Million)
Table 49. Novartis Recent Development
Table 50. Pfizer Company Details
Table 51. Pfizer Business Overview
Table 52. Pfizer Adult and Pediatric Vaccines Product
Table 53. Pfizer Revenue in Adult and Pediatric Vaccines Business (2017-2022) & (US$ Million)
Table 54. Pfizer Recent Development
Table 55. AstraZeneca Company Details
Table 56. AstraZeneca Business Overview
Table 57. AstraZeneca Adult and Pediatric Vaccines Product
Table 58. AstraZeneca Revenue in Adult and Pediatric Vaccines Business (2017-2022) & (US$ Million)
Table 59. AstraZeneca Recent Development
Table 60. Johnson and Johnson Company Details
Table 61. Johnson and Johnson Business Overview
Table 62. Johnson and Johnson Adult and Pediatric Vaccines Product
Table 63. Johnson and Johnson Revenue in Adult and Pediatric Vaccines Business (2017-2022) & (US$ Million)
Table 64. Johnson and Johnson Recent Development
Table 65. Takeda Pharmaceutical Company Details
Table 66. Takeda Pharmaceutical Business Overview
Table 67. Takeda Pharmaceutical Adult and Pediatric Vaccines Product
Table 68. Takeda Pharmaceutical Revenue in Adult and Pediatric Vaccines Business (2017-2022) & (US$ Million)
Table 69. Takeda Pharmaceutical Recent Development
Table 70. Bavarian Nordic Company Details
Table 71. Bavarian Nordic Business Overview
Table 72. Bavarian Nordic Adult and Pediatric Vaccines Product
Table 73. Bavarian Nordic Revenue in Adult and Pediatric Vaccines Business (2017-2022) & (US$ Million)
Table 74. Bavarian Nordic Recent Development
Table 75. LG Life Sciences Company Details
Table 76. LG Life Sciences Business Overview
Table 77. LG Life Sciences Adult and Pediatric Vaccines Product
Table 78. LG Life Sciences Revenue in Adult and Pediatric Vaccines Business (2017-2022) & (US$ Million)
Table 79. LG Life Sciences Recent Development
Table 80. Sinovac Biotech Company Details
Table 81. Sinovac Biotech Business Overview
Table 82. Sinovac Biotech Adult and Pediatric Vaccines Product
Table 83. Sinovac Biotech Revenue in Adult and Pediatric Vaccines Business (2017-2022) & (US$ Million)
Table 84. Sinovac Biotech Recent Development
Table 85. Research Programs/Design for This Report
Table 86. Key Data Information from Secondary Sources
Table 87. Key Data Information from Primary Sources
List of Figures
Figure 1. Adult and Pediatric Vaccines Product Picture
Figure 2. Global Adult and Pediatric Vaccines Market Size, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Adult and Pediatric Vaccines Market Size 2017-2028 (US$ Million)
Figure 4. United States Adult and Pediatric Vaccines Market Size, (US$ Million), 2017 VS 2022 VS 2028
Figure 5. United States Adult and Pediatric Vaccines Market Size 2017-2028 (US$ Million)
Figure 6. United States Adult and Pediatric Vaccines Market Share in Global 2017-2028
Figure 7. Adult and Pediatric Vaccines Report Years Considered
Figure 8. Product Picture of Adult Vaccines
Figure 9. Product Picture of Pediatric Vaccines
Figure 10. Global Adult and Pediatric Vaccines Market Share by Type in 2022 & 2028
Figure 11. Global Adult and Pediatric Vaccines Market Size by Type (2017-2028) & (US$ Million)
Figure 12. Global Adult and Pediatric Vaccines Market Share by Type (2017-2028)
Figure 13. United States Adult and Pediatric Vaccines Market Share by Type in 2022 & 2028
Figure 14. United States Adult and Pediatric Vaccines Market Size by Type (2017-2028) & (US$ Million)
Figure 15. United States Adult and Pediatric Vaccines Market Share by Type (2017-2028)
Figure 16. Product Picture of Hospitals
Figure 17. Product Picture of Medical Care Centers
Figure 18. Product Picture of Others
Figure 19. Global Adult and Pediatric Vaccines Market Share by Application in 2022 & 2028
Figure 20. Global Adult and Pediatric Vaccines Market Size by Application (2017-2028) & (US$ Million)
Figure 21. Global Adult and Pediatric Vaccines Market Share by Application (2017-2028)
Figure 22. United States Adult and Pediatric Vaccines Market Share by Application in 2022 & 2028
Figure 23. United States Adult and Pediatric Vaccines Market Size by Application (2017-2028) & (US$ Million)
Figure 24. United States Adult and Pediatric Vaccines Market Share by Application (2017-2028)
Figure 25. North America Adult and Pediatric Vaccines Market Size Growth Rate 2017-2028 (US$ Million)
Figure 26. U.S. Adult and Pediatric Vaccines Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 27. Canada Adult and Pediatric Vaccines Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 28. Europe Adult and Pediatric Vaccines Market Size Growth Rate 2017-2028 (US$ Million)
Figure 29. Germany Adult and Pediatric Vaccines Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 30. France Adult and Pediatric Vaccines Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 31. U.K. Adult and Pediatric Vaccines Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 32. Italy Adult and Pediatric Vaccines Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 33. Russia Adult and Pediatric Vaccines Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 34. Asia-Pacific Adult and Pediatric Vaccines Market Size Growth Rate 2017-2028 (US$ Million)
Figure 35. China Adult and Pediatric Vaccines Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 36. Japan Adult and Pediatric Vaccines Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 37. South Korea Adult and Pediatric Vaccines Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 38. India Adult and Pediatric Vaccines Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 39. Australia Adult and Pediatric Vaccines Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 40. Taiwan Adult and Pediatric Vaccines Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 41. Indonesia Adult and Pediatric Vaccines Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 42. Thailand Adult and Pediatric Vaccines Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 43. Malaysia Adult and Pediatric Vaccines Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 44. Philippines Adult and Pediatric Vaccines Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 45. Latin America Adult and Pediatric Vaccines Market Size Growth Rate 2017-2028 (US$ Million)
Figure 46. Mexico Adult and Pediatric Vaccines Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 47. Brazil Adult and Pediatric Vaccines Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 48. Argentina Adult and Pediatric Vaccines Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 49. Middle East & Africa Adult and Pediatric Vaccines Market Size Growth Rate 2017-2028 (US$ Million)
Figure 50. Turkey Adult and Pediatric Vaccines Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 51. Saudi Arabia Adult and Pediatric Vaccines Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 52. U.A.E Adult and Pediatric Vaccines Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 53. GlaxoSmithKline Revenue Growth Rate in Adult and Pediatric Vaccines Business (2017-2022)
Figure 54. Sanofi Revenue Growth Rate in Adult and Pediatric Vaccines Business (2017-2022)
Figure 55. Merck Revenue Growth Rate in Adult and Pediatric Vaccines Business (2017-2022)
Figure 56. Novartis Revenue Growth Rate in Adult and Pediatric Vaccines Business (2017-2022)
Figure 57. Pfizer Revenue Growth Rate in Adult and Pediatric Vaccines Business (2017-2022)
Figure 58. AstraZeneca Revenue Growth Rate in Adult and Pediatric Vaccines Business (2017-2022)
Figure 59. Johnson and Johnson Revenue Growth Rate in Adult and Pediatric Vaccines Business (2017-2022)
Figure 60. Takeda Pharmaceutical Revenue Growth Rate in Adult and Pediatric Vaccines Business (2017-2022)
Figure 61. Bavarian Nordic Revenue Growth Rate in Adult and Pediatric Vaccines Business (2017-2022)
Figure 62. LG Life Sciences Revenue Growth Rate in Adult and Pediatric Vaccines Business (2017-2022)
Figure 63. Sinovac Biotech Revenue Growth Rate in Adult and Pediatric Vaccines Business (2017-2022)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
GlaxoSmithKline Sanofi Merck Novartis Pfizer AstraZeneca Johnson and Johnson Takeda Pharmaceutical Bavarian Nordic LG Life Sciences Sinovac Biotech